Private versus Social Incentives for Pharmaceutical Innovation
Year of publication: |
2015
|
---|---|
Authors: | González, Paula ; Macho-Stadler, Ines ; Pérez-Castrillo, David |
Publisher: |
Munich : Center for Economic Studies and ifo Institute (CESifo) |
Subject: | pharmaceuticals | R&D activities | me-too drugs | breakthrough drugs | incremental innovation | radical innovation |
Series: | CESifo Working Paper ; 5672 |
---|---|
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Working Paper |
Language: | English |
Other identifiers: | 845012835 [GVK] hdl:10419/128373 [Handle] RePec:ces:ceswps:_5672 [RePEc] |
Classification: | I10 - Health. General |
Source: |
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2015)
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2016)
-
Importance of tacit knowledge in incremental innovation: Implications from drug discovery cases
Okuyama, Ryo, (2017)
- More ...
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2015)
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2015)
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2016)
- More ...